Jeffrey W. Albers Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Jeffrey W. Albers is of Blueprint Medicines Corp. Currently has a direct ownership of 152,396 shares of BPMC, which is worth approximately $13.5 Million. The most recent transaction as insider was on Nov 03, 2023, when has been sold 1,485 shares (Common Stock) at a price of $60.13 per share, resulting in proceeds of $89,293. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
3.28% 3M change
13.44% 12M change
Total Value Held $13.5 Million

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 03 2023
SELL
Open market or private sale
$89,293 $60.13 p/Share
1,485 Reduced 0.84%
176,050 Common Stock
Nov 03 2023
BUY
Exercise of conversion of derivative security
$53,534 $36.05 p/Share
1,485 Added 0.83%
177,535 Common Stock
Nov 02 2023
SELL
Open market or private sale
$281,330 $60.71 p/Share
4,634 Reduced 2.56%
176,050 Common Stock
Nov 02 2023
BUY
Exercise of conversion of derivative security
$167,055 $36.05 p/Share
4,634 Added 2.5%
180,684 Common Stock
Nov 01 2023
SELL
Open market or private sale
$232,937 $60.02 p/Share
3,881 Reduced 2.16%
176,050 Common Stock
Nov 01 2023
BUY
Exercise of conversion of derivative security
$139,910 $36.05 p/Share
3,881 Added 2.11%
179,931 Common Stock
Sep 28 2023
SELL
Open market or private sale
$346,072 $50.17 p/Share
6,898 Reduced 3.77%
176,050 Common Stock
Sep 28 2023
BUY
Exercise of conversion of derivative security
$12,899 $1.87 p/Share
6,898 Added 3.63%
182,948 Common Stock
Sep 27 2023
SELL
Open market or private sale
$900,755 $49.76 p/Share
18,102 Reduced 9.32%
176,050 Common Stock
Sep 27 2023
BUY
Exercise of conversion of derivative security
$33,850 $1.87 p/Share
18,102 Added 8.53%
194,152 Common Stock
Aug 25 2023
SELL
Open market or private sale
$501,599 $50.16 p/Share
10,000 Reduced 5.37%
176,050 Common Stock
Aug 25 2023
BUY
Exercise of conversion of derivative security
$18,700 $1.87 p/Share
10,000 Added 5.1%
186,050 Common Stock
Aug 24 2023
SELL
Open market or private sale
$743,550 $49.57 p/Share
15,000 Reduced 7.85%
176,050 Common Stock
Aug 24 2023
BUY
Exercise of conversion of derivative security
$28,050 $1.87 p/Share
15,000 Added 7.28%
191,050 Common Stock
Jun 21 2023
BUY
Grant, award, or other acquisition
-
2,600 Added 1.46%
176,050 Common Stock
Mar 06 2023
SELL
Open market or private sale
$440,685 $45.0 p/Share
9,793 Reduced 5.34%
173,450 Common Stock
Dec 05 2022
SELL
Open market or private sale
$1,001,800 $50.09 p/Share
20,000 Reduced 9.84%
183,243 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 8.96%
203,243 Common Stock
Aug 22 2022
SELL
Open market or private sale
$596,185 $70.89 p/Share
8,410 Reduced 4.39%
183,243 Common Stock
Aug 22 2022
BUY
Exercise of conversion of derivative security
$126,234 $15.01 p/Share
8,410 Added 4.2%
191,653 Common Stock
Aug 19 2022
SELL
Open market or private sale
$111,332 $70.02 p/Share
1,590 Reduced 0.86%
183,243 Common Stock
Aug 19 2022
BUY
Exercise of conversion of derivative security
$23,866 $15.01 p/Share
1,590 Added 0.85%
184,833 Common Stock
Aug 16 2022
SELL
Open market or private sale
$1,374,400 $68.72 p/Share
20,000 Reduced 9.84%
183,243 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 8.96%
203,243 Common Stock
Aug 08 2022
SELL
Open market or private sale
$700,700 $70.07 p/Share
10,000 Reduced 5.17%
183,243 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
Director
KYMR
Kymera Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
JWA

Jeffrey W. Albers

Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC